The mechanisms that account for elevated mTOR activity in ADPKD are not fully understood but it appears that cAMP/PKA/ERK and AKT are upstream regulators (Distefano et al., 2009; Rowe et al., 2013; Margaria et al., 2020). The gene discussed is MTOR; the disease is autosomal dominant polycystic kidney disease.